Please check your internet connection and try again.
# Magnesium Sulphate
## Overview
Magnesium sulphate is an essential mineral that plays a crucial role in various physiological processes, including neuromuscular function, cardiac rhythm, and enzyme activity. It is available for intravenous (IV) and intramuscular (IM) administration, as well as topical use.
## Primary Indications
* **Hypomagnesemia:** Treatment of magnesium deficiency.
* **Eclampsia/Preeclampsia:** Prevention and treatment of seizures associated with severe preeclampsia and eclampsia.
* **Torsades de Pointes:** Treatment of this specific type of polymorphic ventricular tachycardia.
* **Asthma:** Adjunctive therapy for severe, acute exacerbations.
* **Constipation:** Oral formulations are used as a laxative. (Note: This request focuses on parenteral magnesium sulfate).
## Adult Dosing
* **Hypomagnesemia:**
* **Severe Deficiency (serum Mg < 1.5 mEq/L):** 4-6 grams IV in divided doses over 10-20 minutes, followed by 1-2 grams/hour IV infusion for maintenance, adjusted based on serum magnesium levels.
* **Mild/Moderate Deficiency:** 2-4 grams IV or IM as a single dose. IM injections should not exceed 2 grams per site.
* **Eclampsia/Preeclampsia:**
* **Loading Dose:** 4-6 grams IV infused over 5-20 minutes.
* **Maintenance Dose:** 1-2 grams/hour IV infusion. Alternatively, 5 grams IM into each buttock may be given if IV access is not readily available, followed by 5 grams IM every 4 hours.
* **Torsades de Pointes:**
* 1-2 grams IV infused over 5-20 minutes. May be followed by an infusion of 0.5-1 gram/hour.
* **Asthma (Adjunctive Therapy):**
* 2 grams IV infused over 15-20 minutes.
## Pediatric Dosing
Dosing in pediatric patients is highly variable and often based on weight and clinical indication. Protocols should be followed.
* **Hypomagnesemia:** 25-50 mg/kg/dose IV or IM every 4-12 hours. Maximum single dose generally 2 grams.
* **Eclampsia:** May follow adult dosing regimens under strict monitoring.
* **Asthma:** 25-40 mg/kg IV infused over 15-30 minutes.
## Dose Adjustments
* **Renal Impairment:** Magnesium is renally excreted. Reduce dose and monitor serum magnesium levels closely in patients with impaired renal function. In severe renal impairment, magnesium administration may be contraindicated.
## Contraindications
* **Hypermagnesemia:** Elevated serum magnesium levels.
* **Heart Block:** Complete heart block or myocardial damage.
* **Hypersensitivity:** Known hypersensitivity to magnesium sulphate.
## Adverse Effects
* **Common:** Flushing, sweating, hypotension, nausea, vomiting, decreased deep tendon reflexes, drowsiness.
* **Serious:** Respiratory depression, cardiac arrhythmias, cardiac arrest, hypermagnesemia (especially with renal impairment).
## Key Drug Interactions
* **Neuromuscular Blocking Agents:** Potentiates neuromuscular blockade, increasing the risk of prolonged respiratory paralysis.
* **Calcium Salts:** Can antagonize the effects of magnesium.
* **Tetracyclines and Quinolones:** Magnesium can chelate with these antibiotics, reducing their absorption. Administer at least 2-4 hours apart.
* **Digoxin:** High doses of IV magnesium may increase the risk of digoxin toxicity.
## Monitoring
* **Serum Magnesium Levels:** Monitor frequently, especially during loading doses and in patients with renal impairment. Target levels vary by indication.
* **Respiratory Rate and Depth:** Assess for signs of respiratory depression.
* **Deep Tendon Reflexes:** Loss of reflexes indicates rising magnesium levels.
* **Blood Pressure and Heart Rate:** Monitor for hypotension and arrhythmias.
* **Urine Output:** Assess renal function.
## Clinical Pearls
* Rapid IV infusion can cause hypotension, flushing, and electrocardiographic changes. Administer IV infusions slowly as recommended.
* IM injections are painful and should be given deep into a large muscle, ideally dividing doses between buttocks.
* In eclampsia, monitor for signs of magnesium toxicity before administering subsequent doses.
* Ensure adequate hydration and renal function before administering magnesium sulphate.
***
***Disclaimer:** This information is intended for clinical professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions. Dosing may vary based on specific institutional protocols and individual patient factors.
